Isthmus Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-3,009
| Closed | -$572K | – | 144 |
|
|
2019
Q1 | $572K | Sell |
3,009
-19,478
| -87% | -$3.7M | 0.14% | 112 |
|
|
2018
Q4 | $756K | Buy |
22,487
+3,621
| +19% | +$122K | 0.23% | 98 |
|
|
2018
Q3 | $796K | Buy |
18,866
+534
| +3% | +$22.5K | 0.2% | 95 |
|
|
2018
Q2 | $587K | Buy |
18,332
+1,427
| +8% | +$45.7K | 0.15% | 105 |
|
|
2018
Q1 | $841K | Buy |
16,905
+495
| +3% | +$24.6K | 0.23% | 82 |
|
|
2017
Q4 | $885K | Buy |
16,410
+89
| +0.5% | +$4.8K | 0.24% | 78 |
|
|
2017
Q3 | $947K | Buy |
16,321
+55
| +0.3% | +$3.19K | 0.27% | 69 |
|
|
2017
Q2 | $803K | Sell |
16,266
-62
| -0.4% | -$3.06K | 0.23% | 82 |
|
|
2017
Q1 | $709K | Buy |
16,328
+337
| +2% | +$14.6K | 0.21% | 89 |
|
|
2016
Q4 | $783K | Sell |
15,991
-285
| -2% | -$14K | 0.24% | 78 |
|
|
2016
Q3 | $758K | Sell |
16,276
-12
| -0.1% | -$559 | 0.24% | 69 |
|
|
2016
Q2 | $874K | Sell |
16,288
-453
| -3% | -$24.3K | 0.29% | 54 |
|
|
2016
Q1 | $749K | Sell |
16,741
-51
| -0.3% | -$2.28K | 0.25% | 63 |
|
|
2015
Q4 | $641K | Buy |
+16,792
| New | +$641K | 0.22% | 79 |
|